MedTrace Logo

Prevalence of NAFLD in T1DM Patients

NCT06445361 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2025-07-28

No results posted yet for this study

Summary

To determine the prevalence of NAFLD in T1DM patients.

Conditions

Interventions

DIAGNOSTIC_TEST

FibroScan

Performance of a FibroScan measurement to determine steatosis and fibrosis.

Sponsors & Collaborators

  • Ziekenhuis Oost-Limburg

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2026-07-01
Completion
2026-07-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06445361 on ClinicalTrials.gov